OLIZU 10 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 10 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1055304010017 -
GGREM
500226070050007 -
Código de barras
7891158107115
O que a fonte publica
- Detentor do registro
- ABBOTT LABORATORIOS DO BRASIL LTDA
- Princípios ativos
- SERPLULIMABE
- Embalagem
- 10 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 10 ML
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- L1G5 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, PD-1/PD-L1
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "OLIZU 10 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 10 ML",
"holder": "ABBOTT LABORATORIOS DO BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891158107115"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "500226070050007",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "56.998.701/0001-16",
"priceRegime": "Regulado",
"productName": "OLIZU",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "10 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 10 ML",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "6743.03",
"icms-12": "7662.54",
"icms-17": "8124.13",
"icms-18": "8223.21",
"icms-19": "8324.73",
"icms-20": "8428.79",
"icms-21": "8535.48",
"icms-22": "8644.91",
"icms-23": "8757.18",
"icms-17.5": "8173.37",
"icms-19.5": "8376.43",
"icms-20.5": "8481.80",
"icms-22.5": "8700.69",
"icms-12-alc": "7031.80",
"icms-17-alc": "7455.40",
"icms-18-alc": "7546.32",
"icms-19-alc": "7639.49",
"icms-20-alc": "7734.98",
"icms-21-alc": "7832.89",
"icms-22-alc": "7933.32",
"icms-23-alc": "8036.34",
"withoutTaxes": "6187.98",
"icms-17.5-alc": "7500.59",
"icms-19.5-alc": "7686.94",
"icms-20.5-alc": "7783.63",
"icms-22.5-alc": "7984.50"
},
"pisCofinsList": "Neutra",
"substanceText": "SERPLULIMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "9109.57",
"icms-12": "10351.79",
"icms-17": "10975.38",
"icms-18": "11109.23",
"icms-19": "11246.38",
"icms-20": "11386.96",
"icms-21": "11531.10",
"icms-22": "11678.93",
"icms-23": "11830.61",
"icms-17.5": "11041.90",
"icms-19.5": "11316.23",
"icms-20.5": "11458.58",
"icms-22.5": "11754.29",
"icms-12-alc": "9721.05",
"icms-17-alc": "10306.65",
"icms-18-alc": "10432.34",
"icms-19-alc": "10561.15",
"icms-20-alc": "10693.16",
"icms-21-alc": "10828.51",
"icms-22-alc": "10967.35",
"icms-23-alc": "11109.77",
"withoutTaxes": "8554.53",
"icms-17.5-alc": "10369.13",
"icms-19.5-alc": "10626.74",
"icms-20.5-alc": "10760.41",
"icms-22.5-alc": "11038.10"
},
"invalidBarcodes": [],
"activeSubstances": [
"SERPLULIMABE"
],
"therapeuticClass": "L1G5 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, PD-1/PD-L1",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1055304010017",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1G5",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:500226070050007"